Octopus Investments’ Development Capital team has provided growth funding to Fuse Universal (Fuse), a provider of next generation learning technology for the workplace. Octopus Investments joins existing investors, Eight Road Ventures and Education Growth Partners, in supporting the company through its next stage of growth. Fuse’s learning platform allows enterprises

QuantifiCare, a specialist in 3D imaging solutions for clinical trials and aesthetic, has raised EUR5 million from LBO France to accelerate its expansion plans and strengthen its prominent position in skin imaging worldwide. QuantifiCare is the first investment of Digital Health 2, LBO France’s new venture fund.   Founded in

Ortho Solutions, a specialist orthopaedic design manufacturer, has secured a GBP2 million funding facility from Independent Growth Finance (IGF) to develop a new range of innovative medical solutions. Founded in 2001, the privately-owned Essex based manufacturer supplies NHS and private hospitals throughout the UK with implant systems used in foot

Palatine Private Equity owned SMP Group of Companies (SMP), has completed a deal to acquire Helm Trust Company Limited (Helm), a trust and corporate services provider based in Jersey. The deal, originally announced in July, has been approved by the Jersey Financial Services Commission.   Helm has now begun trading

Kare Plus National Limited has received a GBP910,000 loan from MEIF Maven WM Debt Finance, part of the Midlands Engine Investment Fund. Kare Plus delivers care and support services through residential establishments including large private hospitals, local councils and to private clients within their own homes, providing them with medical

Arctic Shores, a Manchester-based psychometric assessment provider, has secured a USD5.5 million Series A investment to accelerate its international expansion.  Beringea, the transatlantic venture capital investor, led the transaction with participation from existing shareholders including Candy Ventures.   Arctic Shores was founded in Manchester by Robert Newry and Safe Hammad,

MGB Biopharma, a biopharmaceutical company developing a new class of anti-infectives to address antibiotic resistance, has completed its latest funding round. which was supported by new and existing investors, led by Archangel Investors and including Scottish Investment Bank (the investment arm of Scottish Enterprise, Scotland’s national economic development agency), Barwell